NIH-funded research Career grant

Understanding how MYC contributes to eyelid gland cancer development

Official title: Investigating the Role of MYC in Meibomian Gland Oncogenesis

Funded at Tufts University Boston · NIH-11078802 · Data updated 2026-11-12

This study is looking at how a gene called MYC might influence the growth of a rare type of eyelid cancer that starts in the oil glands, with the goal of finding better ways to diagnose and treat this condition.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionTufts University Boston
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$126,576
NIH project number5K01OD034451-02
Project IDNIH-11078802 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with sebaceous carcinoma of the ocular adnexa, particularly those with aggressive disease features.

Less likely to help

Patients with non-cancerous conditions or those with other types of eyelid tumors may not benefit from this research.

What this research studies

This research investigates the role of the MYC gene in the development of sebaceous carcinomas that arise from the Meibomian glands in the eyelids. The study aims to understand how MYC overexpression, potentially triggered by disruptions in insulin signaling, affects the growth and survival of these cancer cells. By examining the genetic changes associated with these tumors, researchers hope to uncover new insights into their aggressive behavior and the mechanisms behind their spread. This could lead to improved strategies for diagnosis and treatment of this challenging cancer.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for patients with eyelid gland cancers.

How similar studies have gone: While the role of MYC in other cancers has been studied, this specific investigation into its role in Meibomian gland oncogenesis is novel and has not been extensively tested.

Where this research is happening

  • Tufts University Boston
    Boston, United States
    Active

Researchers

  • Principal investigator: Peterson, Cornelia Ward Mary — Tufts University Boston
  • Study coordinator: Peterson, Cornelia Ward Mary

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.